A preliminary study on pro- and anti-inflammatory cytokine profiles in Plasmodium vivax malaria patients from central zone of India

Acta Tropica

Volumn 113, Issue 3, 2010, Pages 263-268

  Jain, Vidhan ^a   Singh, Puspendra P ^a   Silawat, Nipun ^a   Patel, Rakesh ^a   Saxena, Ajay ^a   Bharti, Praveen K ^a   Shukla, Manmohan ^a   Biswas, Sukla ^a   Singh, Neeru ^a  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

Cytokines; ELISA; Malaria; Plasmodium vivax

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEMOGLOBIN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

CONCENTRATION (COMPOSITION); DISEASE TRANSMISSION; DISEASE VECTOR; EPIDEMIOLOGY; IMMUNOASSAY; MALARIA; PARASITIC DISEASE;

AGE DETERMINATION; ANEMIA; ARTICLE; CHILD; CHILL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; INDIA; MAJOR CLINICAL STUDY; MALE; PARASITE TRANSMISSION; PARASITEMIA; PATHOPHYSIOLOGY; PLASMODIUM VIVAX MALARIA; RIGOR; SCHOOL CHILD; SYMPTOMATOLOGY;

INDIA;

PLASMODIUM VIVAX;

EID: 77649179756     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.11.009     Document Type: Article

References (40)

1. al-Yaman F.M., Genton B., Clark I.A. The ratio of reactive nitrogen intermediates to tumor necrosis factor and clinical outcome of falciparum malaria disease. Trans. R. Soc. Trop. Med. Hyg. 1998, 92:417-420.
2. Bate C.A., Taverne J., Playfair J.H. Malaria parasite induces tumor necrosis factor by macrophages. Immunology 1988, 66:600-605.
3. Biemba G., Gordeuk V.R., Thuma P., Weiss G. Markers of inflammation in children with severe malarial anaemia. Trop. Med. Int. Health 2000, 5:256-262.
4. Biswas S., Seth R.K., Tyagi P.K., Sharma S.K., Dash A.P. Naturally acquired immunity and reduced susceptibility to falciparum malaria in two subpopulations of endemic eastern India. Scand. J. Immunol. 2008, 67:177-184.
5. Brown A.E., Teja-Isavadharm P., Webster H.K. Macrophage activation in vivax malaria: fever is associated with increased levels of neopterin and interferon-gamma. Parasite Immunol. 1991, 13:673-679.
6. Carter R., Wijesekera S.K., Karunaweera N.D., Mendis K.N. Cellular mechanism and soluble mediators in the paroxysm of P. vivax malaria. J. Pharm. Pharmacol. 1997, 49:35-41.
7. Daniel-Ribeiro C.T., Zanini G. Autoimmunity and malaria: what are they doing together?. Acta Trop. 2000, 76:205-221.
8. Day N.P., Hien T.T., Schollaardt T., Loc P.P., Chuong L.V., Chau T.T., Mai N.T., Phu N.H., Sinh D.X., White N.J., Ho M. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J. Infect. Dis. 1999, 180:1288-1297.
9. Dodoo D., Omer F.M., Todd J., Akanmori B.D., Koram K.A., Riley E.M. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production invitro predict clinical immunity to Plasmodium falciparum malaria. J. Infect. Dis. 2002, 185:971-979.
10. Druilhe P., Rhodes-Feuillette A., Canivet M., Gentilini M., Peries J. Circulating interferon in patients with P. Falciparum, P. Ovale and P. vivax malaria. Trans. R. Soc. Trop. Med. Hyg. 1982, 76:422-423.
11. Dua V.K., Kar P.K., Sharma V.P. Chloroquine resistant Plasmodium vivax malaria in India. Trop. Med. Int. Health 1996, 1:816-819.
12. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 1997, 61:246-257.
13. Fernandes A.A., Carvalho L.J., Zanini G.M., Ventura A.M., Souza J.M., Cotias P.M., Silva-Filho I.L., Daniel-Ribeiro C.T. Similar cytokine responses and degrees of anaemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region. Clin. Vaccine Immunol. 2008, 15:650-658.
14. Grau G.E., Taylor T.E., Molyneux M.E., Wirima J.J., Vassalli P., Hommel M., Lambert P.H. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 1989, 320:1586-1591.
15. Jain V., Armah H.B., Tongren J.E., Ned R.M., Wilson N.O., Crawford S., Joel P.K., Singh M.P., Nagpal A.C., Dash A.P., Udhayakumar V., Singh N., Stiles J.K. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malaria J. 2008, 7:83.
16. Jason J., Archibald L.K., Nwanyanwu O.C., Bell M., Buchanan I., Larned J., Kazembe P.N., Dobbie H., Parekh B., Byrd M.G., Eick A., Han A. Cytokine and malaria parasitaemia. Clin. Immunol. 2001, 100:208-218.
17. Karunaweera N.D., Carter R., Grau G.E., Kwiatkowski D., Del Giudice G., Mendis K.N. Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. Clin. Exp. Immunol. 1992, 88:499-505.
18. Karunaweera N.D., Grau G.E., Gamage P., Carter R., Mendis K.N. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paraoxysm in Plasmodium vivax malaria. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:3200-3203.
19. Karunaweera N.D., Wijesekera S.K., Wanasekera D., Mendis K.N., Carter R. The paroxysm of Plasmodium vivax malaria. Trends Parasitol. 2003, 19:188-193.
20. Kim T.S., Chung Y.B., Choi H.J., Yang H.J. Changes of serum cytokine profiles in Korean vivax malarial patients after chemotherapy. Parasitol. Res. 2006, 100:183-185.
21. Kochar D.K., Pakalapati D., Kochar S.K., Sirohi P., Khatri M.P., Kochar A., Das A. An unexpected cause of fever and seizure. Lancet 2007, 370(8):908.
22. Kochar D.K., Saxena V., Singh N., Kochar S.K., Kumar S.V., Das A. Plasmodium vivax malaria. Emerg. Infect. Dis. 2005, 11:132-134.
23. Kwaitkowski D., Cannon J.G., Manogue K.R., Cerami A., Dinarello C.A., Greenwood B.M. Tumor necrosis factor production in falciparum malaria and its association with schizont rupture. Clin. Exp. Immunol. 1989, 77:361-366.
24. Kwiatkowski D., Molyneux M.E., Stephens S., Curtis N., Klein N., Pointaire P., Smit M., Allan R., Brewster D.R., Grau G.E., et al. Anti-TNF therapy inhibits fever in cerebral malaria. Q. J. Med. 1993, 86:91-98.
25. Kwiatkowski D., Hill A.V., Sambou I., Twumasi P., Castracane J., Manogue K.R., Cerami A., Brewster D.R., Greenwood B.M. TNF concentration in fatal cerebral, non fatal cerebral and uncomplicated Plasmodium falciparum malaria. Lancet 1996, 336:1201-1204.
26. Mendis K.N., Carter R. The role of cytokines in Plasmodium vivax malaria. Mem. Inst. Oswaldo Cruz. 1992, 87:51-55.
27. Mlambo G., Mutambu S.L., Mduluza T., Soko W., Mbedzi J., Chivenger J., Lanar D.E., Singh S., Carucci D., Gemperli A., Kumar N. Antibody responses to Plasmodium falciparum vaccine candidate antigen in three areas distinct with respect to altitude. Acta Trop. 2006, 100:70-78.
28. Nacher M., Singhasivanon P., Silachamroon U., Treeprasertsuk S., Tosukhowong T., Vannaphan S., Gay F., Mazier D., Looareesuwan S. Decreased haemoglobin concentrations, hyperparasitaemia, and severe malaria are associated with increased Plasmodium falciparum gametocyte carriage. J. Parasitol. 2002, 88:97-101.
29. Naotunne T.S., Karunaweera N.D., Del Giudice G., Kularatne M.U., Grau G.E., Carter R., Mendis K.N. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. J. Exp. Med. 1991, 173:523-529.
30. Newton C.R., Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Ann. Trop. Med. Parasitol. 1998, 79:1-53.
31. Richards A.L. Tumor necrosis factor and associated cytokines in the host's response to malaria. Int. J. Parasitol. 1997, 27:1251-1263.
32. Ritter K., Kuhlancord R., Thomssen R., Bommer W. Prolonged haemolytic anaemia in malaria and autoantibodies against triosephosphate isomerase. Lancet 1993, 342:1333-1334.
33. Seoh J.Y., Khan M., Park S.H., Park H.K., Shin M.H., Ha E.H., Lee B.E., Yoo K., Han H.S., Oh S., Wi J.H., Hong C.K., Oh C.H., Kim Y.A., Park J.W. Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without hyperpyrexia. Am. J. Trop. Med. Hyg. 2003, 68:102-106.
34. Shaffer N., Grau G.E., Hedberg K., Davachi F., Lyamba B., Hightower A.W., Breman J.G., Phuc N.D. Tumor necrosis factor and severe malaria. J. Infect. Dis. 1991, 163:96-101.
35. Singh N., Mishra S.S., Singh M.P., Sharma V.P. Seasonlality of Plasmodium vivax and P. falciparum in tribal villages in central India (1987-1995). Ann. Trop. Med. Parasitol. 2000, 94:101-112.
36. Singh N., Chand S.K., Mishra A.K., Bharti P.K., Singh M.P., Ahluwalia T.P., Dash A.P. Epidemiology of malaria in an area of low transmission in central India. Am. J. Trop. Med. Hyg. 2006, 75:812-816.
37. Singh R.K. Emergence of chloroquine resistance vivax malaria in south Bihar (India). Trans. R. Soc. Trop. Med. Hyg. 2000, 94:327.
38. Torre D., Ferrario G., Matteelli A., Speranza F., Giola M., Pugliese A., Cantamessa C., Carosi G., Fiori G.P. Levels of circulating nitrate/nitrite and gamma interferon not increased in uncomplicated malaria. Infection 1998, 26:301.
39. Yeom J.S., Park S.H., Ryu S.H., Park H.K., Woo S.Y., Ha E.H., Lee B.E., Yoo K., Lee J.H., Kim K.H., Kim S., Kim Y.A., Ahn S.Y., Oh S., Park H.J., Min G.S., Seoh J.Y., Park J.W. Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without hepatic dysfunction. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:687-691.
40. Zeyrek F.Y., Kurcer M.A., Zeyrek D., Simsek Z. Parasite density and serum cytokine levels in Plasmodium vivax malaria in Turkey. Parasite Immunol. 2006, 28:201-207.